error on quality of life  : a qualitative study. Clin Exp Ophthalmol
2018 ; 95(7) : 575-87.
[4] Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of
myopia and high myopia and temporal trends from 2000 through
2050. Ophthalmology 2016 ; 123(5) : 1036-42.
[5] Leo SW. Current approaches to myopia control. Curr Opin Oph-
thalmol 2017 ; 28(3) : 267-75.
[6] Ohno-Matsui K, Lai TY, Lai CC, Cheung CM. Updates of patho-
logic myopia. Prog Retin Eye Res 2016 ; 52 : 156-87.
[7] Zhu Y, Zhang T, Xu G, Peng L. Anti-vascular endothelial growth
factor for choroidal neovascularisation in people with pathological
myopia. Cochrane Database Syst Rev 2016 ; 12 : CD011160.
[8] COMET-Group. Myopia stabilization and associated factors
among participants in the Correction of Myopia Evaluation Trial
(COMET). Invest Ophthalmol Vis Sci 2013 ; 54(13) : 7871-84.
[9] Williams KM, Verhoeven VJ, Cumberland P, et al. Prevalence of
refractive error in Europe  : the European Eye Epidemiology (E(3))
Consortium. Eur J Epidemiol 2015 ; 30(4) : 305-15.
[10] Dolgin E. The myopia boom. Nature 2015 ; 519(7543) : 276-8.
[11] Zheng YF, Pan CW, Chay J, et al. The economic cost of myopia
in adults aged over 40 years in Singapore. Invest Ophthalmol Vis Sci
2013 ; 54(12) : 7532-7.
[12] McKnight CM, Sherwin JC, Yazar S, et al. Myopia in young
adults is inversely related to an objective marker of ocular sun expo-
sure : the Western Australian Raine cohort study. Am J Ophthalmol
2014 ; 158(5) : 1079-85.
[13] Kempen JH, Mitchell P, Lee KE, et al. The prevalence of refrac-
tive errors among adults in the United States, Western Europe, and
Australia. Arch Ophthalmol 2004 ; 122(4) : 495-505.
[14] Verhoeven VJ, Hysi PG, Wojciechowski R, et al. Genome-wide
meta-analyses of multiancestry cohorts identify multiple new suscep-
tibility loci for refractive error and myopia. Nat Genet 2013 ; 45(3) :